From proactive investors
Zelira Therapeutics and Levin Health talk upcoming chronic pain clinical trialZelira Therapeutics Ltd's (ASX:ZLD) (OTCMKTS:ZLDAF) Dr Oludare Odumosu and Levin Health Limited's Mark Brayshaw discuss plans for its upcoming chronic pain clinical trial. Levin will use Zelira's ZTL-106 formulation for testing on retired athletes in a chronic pain treatment study at La Trobe University in Melbourne. The trial will be sponsored by Levin, which will pay Zelira to design and manage the study, while both companies will share any commercialisation profits.
- Forums
- ASX - By Stock
- ZLD
- Ann: ZLD and Levin Health to Conduct Chronic Pain Clinical Trial
Ann: ZLD and Levin Health to Conduct Chronic Pain Clinical Trial, page-16
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
|
|||||
Last
70.0¢ |
Change
-0.005(0.71%) |
Mkt cap ! $7.943M |
Open | High | Low | Value | Volume |
73.5¢ | 73.5¢ | 70.0¢ | $1.176K | 1.633K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 67.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
70.0¢ | 1846 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.670 |
2 | 5881 | 0.650 |
1 | 3000 | 0.630 |
1 | 9000 | 0.600 |
2 | 3187 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.700 | 1846 | 1 |
0.710 | 484 | 1 |
0.720 | 286 | 1 |
0.735 | 14095 | 1 |
0.750 | 813 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online